Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Forsyth

Showing results (1-10 of 80) with videos related to

Pageof 8
Sort By:
Journal of Air Transport Management|June 24, 2020
Open Skies in ASEANPeter Forsyth, John King, Cherry Lyn Rodolfo
Journal of Air Transport Management|September 21, 2020
Covid -19, the collapse in passenger demand and airport chargesPeter Forsyth, Cathal Guiomard, Hans-Martin Niemeier
The Oncologist|July 6, 2021
BRAF Inhibitor Therapy-Related Encephalitis in a Patient with Metastatic MelanomaNalan Akgul Babacan, Edwin Peguero, Peter Forsyth, et al.
Leukemia & Lymphoma|June 3, 2014
What is the optimal dose of high-dose methotrexate in the initial treatment of primary central nervous system lymphoma?Samir Dalia, Samantha Price, Peter Forsyth, et al.
Therapeutic Advances in Drug Safety|August 2, 2014
Evidence-based case report: multiple thrombotic episodes associated with lenalidomide and dexamethasone therapy for multiple myelomaGordon F Rushworth, Stephen J Leslie, Peter Forsyth, et al.
Psycho-Oncology|July 26, 2005
An open-label study of the effects of bupropion SR on fatigue, depression and quality of life of mixed-site cancer patients and their partnersErin L Moss, J Steven A Simpson, Guy Pelletier, et al.
Leukemia Research Reports|October 23, 2020
Myasthenia Gravis and Large Granular Lymphocytic Leukemia: a rare associationYumeng Zhang, Christa Varnadoe, Ankita Tandon, et al.
Hematology/Oncology Clinics of North America|November 10, 2021
Leptomeningeal DiseaseYolanda Piña, Dorothee Gramatzki, Peter Forsyth, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|November 28, 2008
A feasibility study to assess the integration of a pharmacist into neurooncology clinicLouise Delaney, Carole Chambers, Gloria Roldán, et al.
Neuro-Oncology|November 27, 2018
Integrative cross-platform analyses identify enhanced heterotrophy as a metabolic hallmark in glioblastomaAntony H Prabhu, Shiva Kant, Pravin Kesarwani, et al.
Pageof 8

Showing results (1-10 of 80) with videos related to

Sort By:
Pageof 8
Journal of Air Transport Management|June 24, 2020
Open Skies in ASEANPeter Forsyth, John King, Cherry Lyn Rodolfo
Journal of Air Transport Management|September 21, 2020
Covid -19, the collapse in passenger demand and airport chargesPeter Forsyth, Cathal Guiomard, Hans-Martin Niemeier
The Oncologist|July 6, 2021
BRAF Inhibitor Therapy-Related Encephalitis in a Patient with Metastatic MelanomaNalan Akgul Babacan, Edwin Peguero, Peter Forsyth, et al.
Leukemia & Lymphoma|June 3, 2014
What is the optimal dose of high-dose methotrexate in the initial treatment of primary central nervous system lymphoma?Samir Dalia, Samantha Price, Peter Forsyth, et al.
Therapeutic Advances in Drug Safety|August 2, 2014
Evidence-based case report: multiple thrombotic episodes associated with lenalidomide and dexamethasone therapy for multiple myelomaGordon F Rushworth, Stephen J Leslie, Peter Forsyth, et al.
Psycho-Oncology|July 26, 2005
An open-label study of the effects of bupropion SR on fatigue, depression and quality of life of mixed-site cancer patients and their partnersErin L Moss, J Steven A Simpson, Guy Pelletier, et al.
Leukemia Research Reports|October 23, 2020
Myasthenia Gravis and Large Granular Lymphocytic Leukemia: a rare associationYumeng Zhang, Christa Varnadoe, Ankita Tandon, et al.
Hematology/Oncology Clinics of North America|November 10, 2021
Leptomeningeal DiseaseYolanda Piña, Dorothee Gramatzki, Peter Forsyth, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|November 28, 2008
A feasibility study to assess the integration of a pharmacist into neurooncology clinicLouise Delaney, Carole Chambers, Gloria Roldán, et al.
Neuro-Oncology|November 27, 2018
Integrative cross-platform analyses identify enhanced heterotrophy as a metabolic hallmark in glioblastomaAntony H Prabhu, Shiva Kant, Pravin Kesarwani, et al.
Pageof 8